As of 2026-04-07, the Intrinsic Value of Neximmune Inc (NEXI) is -24.64 USD. This NEXI valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Neximmune Inc is -24,637,800.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Neximmune Inc (NEXI) is overvalued by 24,637,800.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -24.64 - -24.64 | -24.64 | -24,637,800.00% |
| P/E | (99.73) - (111.36) | (106.80) | -106804650.5% |
| DDM - Stable | (46.13) - (189.36) | (117.74) | -117744799.5% |
| DDM - Multi | (129.59) - (421.93) | (199.27) | -199268744.2% |
| Market Cap (mil) | 0.00 |
| Beta | 4,755.51 |
| Outstanding shares (mil) | 4.18 |
| Enterprise Value (mil) | -2.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.91% |
| Cost of Debt | 5.00% |
| WACC | 6.29% |